Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

High glucose levels promote the proliferation of breast cancer cells through GTPases.

Hou Y, Zhou M, Xie J, Chao P, Feng Q, Wu J.

Breast Cancer (Dove Med Press). 2017 Jun 13;9:429-436. doi: 10.2147/BCTT.S135665. eCollection 2017.

2.

Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic Review.

Khodadadi S, Sobhani N, Mirshekar S, Ghiasvand R, Pourmasoumi M, Miraghajani M, Dehsoukhteh SS.

Int J Prev Med. 2017 May 25;8:35. doi: 10.4103/2008-7802.207035. eCollection 2017. Review.

3.

Biochemical changes in the injured brain.

Sahu S, Nag DS, Swain A, Samaddar DP.

World J Biol Chem. 2017 Feb 26;8(1):21-31. doi: 10.4331/wjbc.v8.i1.21.

4.

Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Puchalska P, Crawford PA.

Cell Metab. 2017 Feb 7;25(2):262-284. doi: 10.1016/j.cmet.2016.12.022. Review.

PMID:
28178565
5.

Tumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor Therapy.

Woolf EC, Syed N, Scheck AC.

Front Mol Neurosci. 2016 Nov 16;9:122. eCollection 2016. Review.

6.

Leucine-rich diet alters the 1H-NMR based metabolomic profile without changing the Walker-256 tumour mass in rats.

Viana LR, Canevarolo R, Luiz AC, Soares RF, Lubaczeuski C, Zeri AC, Gomes-Marcondes MC.

BMC Cancer. 2016 Oct 3;16(1):764.

7.

Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System.

Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB.

Nutr Metab (Lond). 2016 Aug 12;13:52. doi: 10.1186/s12986-016-0113-y. eCollection 2016. Erratum in: Nutr Metab (Lond). 2016;13(1):61.

8.

The Dark Side of Cell Fusion.

Bastida-Ruiz D, Van Hoesen K, Cohen M.

Int J Mol Sci. 2016 Apr 28;17(5). pii: E638. doi: 10.3390/ijms17050638. Review.

9.

Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.

Morscher RJ, Aminzadeh-Gohari S, Hauser-Kronberger C, Feichtinger RG, Sperl W, Kofler B.

Oncotarget. 2016 Mar 29;7(13):17060-73. doi: 10.18632/oncotarget.7929.

10.

FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice.

Stemmer K, Zani F, Habegger KM, Neff C, Kotzbeck P, Bauer M, Yalamanchilli S, Azad A, Lehti M, Martins PJ, Müller TD, Pfluger PT, Seeley RJ.

Diabetologia. 2015 Oct;58(10):2414-23. doi: 10.1007/s00125-015-3668-7. Epub 2015 Jun 23.

11.

Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.

Poff AM, Ward N, Seyfried TN, Arnold P, D'Agostino DP.

PLoS One. 2015 Jun 10;10(6):e0127407. doi: 10.1371/journal.pone.0127407. eCollection 2015.

12.

Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.

Morscher RJ, Aminzadeh-Gohari S, Feichtinger RG, Mayr JA, Lang R, Neureiter D, Sperl W, Kofler B.

PLoS One. 2015 Jun 8;10(6):e0129802. doi: 10.1371/journal.pone.0129802. eCollection 2015.

13.

Mechanisms by which low glucose enhances the cytotoxicity of metformin to cancer cells both in vitro and in vivo.

Zhuang Y, Chan DK, Haugrud AB, Miskimins WK.

PLoS One. 2014 Sep 25;9(9):e108444. doi: 10.1371/journal.pone.0108444. eCollection 2014.

14.

Ketone strong: emerging evidence for a therapeutic role of ketone bodies in neurological and neurodegenerative diseases.

Seyfried TN.

J Lipid Res. 2014 Sep;55(9):1815-7. doi: 10.1194/jlr.E052944. Epub 2014 Jul 11. No abstract available.

15.

Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.

Meidenbauer JJ, Ta N, Seyfried TN.

Nutr Metab (Lond). 2014 May 22;11:23. doi: 10.1186/1743-7075-11-23. eCollection 2014.

16.

Ketogenic diets, mitochondria, and neurological diseases.

Gano LB, Patel M, Rho JM.

J Lipid Res. 2014 Nov;55(11):2211-28. doi: 10.1194/jlr.R048975. Epub 2014 May 20. Review.

17.

The ketogenic diet for the treatment of malignant glioma.

Woolf EC, Scheck AC.

J Lipid Res. 2015 Jan;56(1):5-10. doi: 10.1194/jlr.R046797. Epub 2014 Feb 6. Review.

18.

Cancer as a metabolic disease: implications for novel therapeutics.

Seyfried TN, Flores RE, Poff AM, D'Agostino DP.

Carcinogenesis. 2014 Mar;35(3):515-27. doi: 10.1093/carcin/bgt480. Epub 2013 Dec 16. Review.

19.

Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.

Schugar RC, Huang X, Moll AR, Brunt EM, Crawford PA.

PLoS One. 2013 Aug 29;8(8):e74806. doi: 10.1371/journal.pone.0074806. eCollection 2013.

20.

Prediagnostic body weight and survival in high grade glioma.

Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM.

J Neurooncol. 2013 Aug;114(1):79-84. doi: 10.1007/s11060-013-1150-2. Epub 2013 May 11.

Supplemental Content

Support Center